Showing posts with label quest pharma. Show all posts
Showing posts with label quest pharma. Show all posts
Sunday, July 11, 2010
Oregovomab - Quest PharmaTech Announces Formation of Clinical Advisory Panel - MarketWatch
"All members of the Panel have a keen interest in innovative improvements in the area of ovarian cancer and see a great opportunity to advance the previous learning with Oregovomab in the context of combination therapies to better access the potential of the immune response to bring clinical benefit to ovarian cancer patients," commented Dr. Nicodemus. "We are excited about the potential of the approach for these three planned clinical trials."
Subscribe to:
Posts
(
Atom
)
